As I spent time at home recuperating after the procedure, the emotional turmoil continued. I wept. I searched. I prayed. I ...

Chicago-based biotech Cour Pharmaceuticals announced the hiring of former Acelyrin executive Paul M. Peloso, MD as chief ...

Dr. Peloso to lead COUR’s clinical development programs as the company advances towards late-stage developmentCHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage ...

The combined assessment of analysts suggests that 'Revenue- Established Brands- Int'l- Non-Opioid Pain, Bone and Dermatology- Arcoxia' will likely reach $67.07 million. The estimate indicates a ...

Valdecoxib (Bextra) was approved by the FDA and launched in 2002. In that same year, the European regulatory authority approved 2 other coxibs: etoricoxib (Arcoxia) and parecoxib sodium (Dynastat), ...

After hours: May 24 at 7:46 PM EDT Loading Chart for OGN ...